309 related articles for article (PubMed ID: 32219334)
1. Bufalin down-regulates Axl expression to inhibit cell proliferation and induce apoptosis in non-small-cell lung cancer cells.
Kim NY; Suh YA; Kim S; Lee C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32219334
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effect of luteolin is mediated by downregulation of TAM receptor tyrosine kinases, but not interleukin-8, in non-small cell lung cancer cells.
Lee YJ; Lim T; Han MS; Lee SH; Baek SH; Nan HY; Lee C
Oncol Rep; 2017 Feb; 37(2):1219-1226. PubMed ID: 28035396
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-induced downregulation of Axl receptor tyrosine kinase inhibits cell proliferation and circumvents chemoresistance in non-small lung cancer cells.
Kim KC; Baek SH; Lee C
Int J Oncol; 2015 Dec; 47(6):2296-303. PubMed ID: 26498137
[TBL] [Abstract][Full Text] [Related]
4. Mistletoe (Viscum album) extract targets Axl to suppress cell proliferation and overcome cisplatin- and erlotinib-resistance in non-small cell lung cancer cells.
Kim S; Kim KC; Lee C
Phytomedicine; 2017 Dec; 36():183-193. PubMed ID: 29157814
[TBL] [Abstract][Full Text] [Related]
5. Carvacrol Targets AXL to Inhibit Cell Proliferation and Migration in Non-small Cell Lung Cancer Cells.
Jung CY; Kim SY; Lee C
Anticancer Res; 2018 Jan; 38(1):279-286. PubMed ID: 29277784
[TBL] [Abstract][Full Text] [Related]
6. Axl receptor tyrosine kinase is a novel target of apigenin for the inhibition of cell proliferation.
Kim KC; Choi EH; Lee C
Int J Mol Med; 2014 Aug; 34(2):592-8. PubMed ID: 24926787
[TBL] [Abstract][Full Text] [Related]
7. AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells.
Kim D; Bach DH; Fan YH; Luu TT; Hong JY; Park HJ; Lee SK
Cell Death Dis; 2019 May; 10(5):361. PubMed ID: 31043587
[TBL] [Abstract][Full Text] [Related]
8. Bufalin inhibits the malignant development of non-small cell lung cancer by mediating the circ_0046264/miR-522-3p axis.
Jin J; Yao Z; Qin H; Wang K; Xin X
Biotechnol Lett; 2021 Jun; 43(6):1229-1240. PubMed ID: 33534015
[TBL] [Abstract][Full Text] [Related]
9. Metformin targets Axl and Tyro3 receptor tyrosine kinases to inhibit cell proliferation and overcome chemoresistance in ovarian cancer cells.
Kim NY; Lee HY; Lee C
Int J Oncol; 2015 Jul; 47(1):353-60. PubMed ID: 25975389
[TBL] [Abstract][Full Text] [Related]
10. Axl is a novel target of celastrol that inhibits cell proliferation and migration, and increases the cytotoxicity of gefitinib in EGFR mutant non‑small cell lung cancer cells.
Lee YJ; Kim SY; Lee C
Mol Med Rep; 2019 Apr; 19(4):3230-3236. PubMed ID: 30816529
[TBL] [Abstract][Full Text] [Related]
11. Growth Suppression in Lung Cancer Cells Harboring EGFR-C797S Mutation by Quercetin.
Huang KY; Wang TH; Chen CC; Leu YL; Li HJ; Jhong CL; Chen CY
Biomolecules; 2021 Aug; 11(9):. PubMed ID: 34572484
[TBL] [Abstract][Full Text] [Related]
12. Mechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance.
Xiong R; Sun XX; Wu HR; Xu GW; Wang GX; Sun XH; Xu MQ; Xie MR
Thorac Cancer; 2020 Jan; 11(1):156-165. PubMed ID: 31777195
[TBL] [Abstract][Full Text] [Related]
13. Lotus (Nelumbo nucifera) seedpod extract inhibits cell proliferation and induces apoptosis in non-small cell lung cancer cells via downregulation of Axl.
Kim NY; Yang IJ; Kim S; Lee C
J Food Biochem; 2021 Feb; 45(2):e13601. PubMed ID: 33381866
[TBL] [Abstract][Full Text] [Related]
14. Development of the phenylpyrazolo[3,4-
Lee HJ; Pham PC; Pei H; Lim B; Hyun SY; Baek B; Kim B; Kim Y; Kim MH; Kang NW; Min HY; Kim DD; Lee J; Lee HY
Theranostics; 2021; 11(4):1918-1936. PubMed ID: 33408789
[No Abstract] [Full Text] [Related]
15. Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer.
Bae SY; Hong JY; Lee HJ; Park HJ; Lee SK
Oncotarget; 2015 Apr; 6(12):10146-60. PubMed ID: 25760142
[TBL] [Abstract][Full Text] [Related]
16. MET and AXL inhibitor NPS-1034 exerts efficacy against lung cancer cells resistant to EGFR kinase inhibitors because of MET or AXL activation.
Rho JK; Choi YJ; Kim SY; Kim TW; Choi EK; Yoon SJ; Park BM; Park E; Bae JH; Choi CM; Lee JC
Cancer Res; 2014 Jan; 74(1):253-62. PubMed ID: 24165158
[TBL] [Abstract][Full Text] [Related]
17. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.
Linger RM; Cohen RA; Cummings CT; Sather S; Migdall-Wilson J; Middleton DH; Lu X; Barón AE; Franklin WA; Merrick DT; Jedlicka P; DeRyckere D; Heasley LE; Graham DK
Oncogene; 2013 Jul; 32(29):3420-31. PubMed ID: 22890323
[TBL] [Abstract][Full Text] [Related]
18. AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
Taniguchi H; Yamada T; Wang R; Tanimura K; Adachi Y; Nishiyama A; Tanimoto A; Takeuchi S; Araujo LH; Boroni M; Yoshimura A; Shiotsu S; Matsumoto I; Watanabe S; Kikuchi T; Miura S; Tanaka H; Kitazaki T; Yamaguchi H; Mukae H; Uchino J; Uehara H; Takayama K; Yano S
Nat Commun; 2019 Jan; 10(1):259. PubMed ID: 30651547
[TBL] [Abstract][Full Text] [Related]
19. Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer.
Wang Y; Xia H; Zhuang Z; Miao L; Chen X; Cai H
Cell Death Dis; 2014 May; 5(5):e1227. PubMed ID: 24832599
[TBL] [Abstract][Full Text] [Related]
20. Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo.
Wu SH; Bau DT; Hsiao YT; Lu KW; Hsia TC; Lien JC; Ko YC; Hsu WH; Yang ST; Huang YP; Chung JG
Environ Toxicol; 2017 Apr; 32(4):1305-1317. PubMed ID: 27444971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]